Guangdong Maijinjia Biotechnologies Co., Ltd. is a privately held company and is a one-of-a- kind joint venture between Danish and Chinese founders. Together our founders bring a total of more than 50 years of experience with small RNAs, modified oligonucleotides, patenting, clinical trials, biotechnology and business in general to the table. Our investors are:

Series-A investment

Guangzhou Science City Venture Capital Co., Ltd.

Guangzhou Science City Venture Capital Co., Ltd. is a venture capital management company wholly owned by Science City (Guangzhou) Investment Group Co., Ltd. in March 2018. Currently, it focuses on investing in outstanding new-generation information technology, artificial intelligence, and biomedical start-ups.

Angel Investment

Guangzhou Aoqi Shengjia Technology Partnership (Limited Partnership)

was established on December 10, 2018.Its business scope focuses on medical technology transfer services;Medical technical consultation and exchange services;Medical technology extension services. Currently, the company has invested one company.